The utility of tranexamic acid (TXA) in patients with Marfan syndrome (MFS) is uncertain given associated aberrations within the vasculature and clotting cascade. Therefore, this study aimed to assess the association of TXA use with intraoperative blood loss and allogeneic blood transfusions in patients with MFS who underwent spinal arthrodesis.
We queried our institutional database for MFS patients who underwent spinal arthrodesis for scoliosis between 2000 and 2020 by one surgeon. We excluded procedures spanning < 4 vertebral levels, those using anterior or combined anterior/posterior approaches, and those involving growing rods, postoperative infection, or spondylolisthesis. Fifty-two patients met our criteria, of whom 22 were treated with TXA and 30 were not. Mean differences in blood loss, transfusion volume, and proportions receiving transfusion were compared between TXA and the control groups using Student t, chi-squared, or Fisher exact tests. Alpha = 0.05.
MFS patients treated with TXA experienced less mean (± standard deviation) intraoperative blood loss (1023 ± 534 mL) compared to the control group (1436 ± 1022 mL) (p = 0.01). The TXA group had estimated blood volume loss of 27% ± 16% compared to 36% ± 21% for controls (p = 0.05). No differences were found in allogeneic transfusion rate (p = 0.66) or transfusion volume (p = 0.15).
We found an association between TXA use and reduced blood loss during surgical treatment of MFS-associated scoliosis, suggesting that the connective tissue deficiency in MFS does not interfere with TXA’s mechanism of action.
Level of evidence
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352:337–339
Pyeritz RE, Francke U (1993) The second international symposium on the Marfan syndrome. Am J Med Genet 47:127–135
Sponseller PD, Bhimani M, Solacoff D et al (2000) Results of brace treatment of scoliosis in Marfan syndrome. Spine (Phila Pa 1976) 25:2350–2354
Sponseller PD, Hobbs W, Riley LH III et al (1995) The thoracolumbar spine in Marfan syndrome. J Bone Joint Surg Am 77:867–876
Bick RL (1979) Vascular disorders associated with thrombohemorrhagic phenomena. Semin Thromb Hemost 5:167–183
Bridges AB, Gray JR, McLaren M et al (1993) Endothelial cell and platelet function in Marfan’s syndrome. Endothelium 1:203–206
Erdohazi M, Cowie V, Lo SS (1964) A case of haemophilia with Marfan’s syndrome. Br Med J 1:102–103
Humphries JE, Stouffer GA, Kelly TE et al (1991) Hypercoagulability in a patient with Marfan syndrome. J Med Genet 28:349–351
Kornhuber KTI, Seidel H, Pujol C et al (2019) Hemostatic abnormalities in adult patients with Marfan syndrome. Cardiovasc Diagn Ther 9:S209–S220
Moran MM, Kroon D, Tredwell SJ et al (1995) The role of autologous blood transfusion in adolescents undergoing spinal surgery. Spine (Phila Pa 1976) 20:532–536
Liang W, Yu B, Wang Y et al (2015) Comparison of posterior correction results between Marfan syndrome scoliosis and adolescent idiopathic scoliosis-a retrospective case-series study. J Orthop Surg Res 10:73
Lipton GE, Guille JT, Kumar SJ (2002) Surgical treatment of scoliosis in Marfan syndrome: guidelines for a successful outcome. J Pediatr Orthop 22:302–307
Palmisani M, Dema E, Rava A et al (2019) Surgical treatment of spinal deformities in Marfan syndrome: Long-term follow-up results using different instrumentations. J Craniovertebr Junction Spine 10:172–178
Di Silvestre M, Greggi T, Giacomini S et al (2005) Surgical treatment for scoliosis in Marfan syndrome. Spine (Phila Pa) 30:E597–E604
Kurucan E, Bernstein DN, Ying M et al (2019) Trends in spinal deformity surgery in Marfan syndrome. Spine J 19:1934–1940
Zenner J, Hitzl W, Meier O et al (2014) Surgical outcomes of scoliosis surgery in Marfan syndrome. J Spinal Disord Tech 27:48–58
Hunt BJ (2015) The current place of tranexamic acid in the management of bleeding. Anaesthesia 70(Suppl 1):50–3,e18
Chauncey JM, Wieters JS (2021) Tranexamic Acid.
Anand A, Melvin JS (2016) Tranexamic acid in hip and knee arthroplasty. J Am Acad Orthop Surg 24:e59
Lin ZX, Woolf SK (2016) Safety, Efficacy, and Cost-effectiveness of Tranexamic Acid in Orthopedic Surgery. Orthopedics 39:119–130
Slattery C, Kark J, Wagner T et al (2019) The use of tranexamic acid to reduce surgical blood loss: a review basic science, subspecialty studies, and the evolution of use in Spine deformity surgery. Clin Spine Surg 32:46–50
Yoo JS, Ahn J, Karmarkar SS et al (2019) The use of tranexamic acid in spine surgery. Ann Transl Med 7:S172
Qiao J, Xu L, Liu Z et al (2016) Surgical treatment of scoliosis in Marfan syndrome: outcomes and complications. Eur Spine J 25:3288–3293
Shirley ED, Sponseller PD (2009) Marfan syndrome. J Am Acad Orthop Surg 17:572–581
Jones KB, Erkula G, Sponseller PD et al (2002) Spine deformity correction in Marfan syndrome. Spine (Phila Pa 1976) 27:2003–2012
Chung AS, Renfree S, Lockwood DB et al (2019) Syndromic scoliosis: national trends in surgical management and inpatient hospital outcomes: a 12-year analysis. Spine (Phila Pa 1976) 44:1564–1570
Li ZC, Liu ZD, Dai LY (2011) Surgical treatment of scoliosis associated with Marfan syndrome by using posterior-only instrumentation. J Pediatr Orthop B 20:63–66
von Kodolitsch Y, Demolder A, Girdauskas E et al (2019) Features of Marfan syndrome not listed in the Ghent nosology - the dark side of the disease. Expert Rev Cardiovasc Ther 17:883–915
Nadler SB, Hidalgo JH, Bloch T (1962) Prediction of blood volume in normal human adults. Surgery 51:224–232
For their editorial assistance, we thank Jenni Weems, MS, Kerry Kennedy, BA, and Rachel Box, MS, in the Editorial Services group of The Johns Hopkins Department of Orthopaedic Surgery.
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Conflict of interest
The authors have no conflicts of interest to report.
This study was approved by the Johns Hopkins Medicine Institutional Review Boards.
Consent to participate
Formal consent was not required for this type of study.
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ikwuezunma, I.A., Margalit, A. & Sponseller, P.D. Tranexamic acid use is associated with reduced intraoperative blood loss during spine surgery for Marfan syndrome. Spine Deform (2021). https://doi.org/10.1007/s43390-021-00416-1
- Connective tissue deficiency
- Intraoperative blood loss
- Marfan syndrome
- Posterior spinal arthrodesis
- Risk modification
- Syndromic scoliosis
- Tranexamic acid